Skip to content
022- 49731419 / 022- 49731411 | info@asstonpharmaceuticals.com
FacebookTwitterInstagramPinterest
ASSTON PHARMACEUTICALS LTD Logo
  • Home
  • About Us
  • Products
  • Gallery
  • Our Team
  • Investor Relations
    • Governance
    • Board of Directors & KMPs
    • Key Contact
    • Policies
    • Financial Information
    • IPO
      • DRAFT RED HERRING PROSPECTUS
      • RED HERRING PROSPECTUS
      • PROSPECTUS
      • MCMD
      • OTHER DOCUMENTS
    • Corporate Announcement
    • Annual Report
  • Contact Us

MCMD

Home/MCMD
MCMDTheBDIT2025-07-07T12:22:24+00:00

Material Documents

  • E MOA

  • E AOA

  • Certificate of Incorporation

  • Fresh Certificate of Incorporation
  • BR IPO Resolution

  • Shareholder Resolution IPO
  • Asston Pharma RFS May 2025
  • Cerificate for Tax Benefits
  • Consents
  • Certificate On KPI
  • Asston-Due_Diligence_Certificate-RHP_03.07.2025
  • Due Diligence certificate BSE_DRHP
  • BR RHP Approval
  • BR DRHP Approval
  • Asston Pharmaceuticals IP letter

Material Contract

  • MOU Agreement
  • RTA Agreement
  • Market Making Asston JSK
  • Bankers to the issue Agreement
  • Underwriting Agreement
  • Addendum to Underwriting
  • NSDL Tripartite Agreement
  • CDSL Tripartite Agreement
  • Syndicate Agreement Asston IPO

USEFUL LINKS

  • Home
  • About Us
  • Our Products
  • Contact Us
  • Privacy Policy

GET IN TOUCH

  • 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane – 400 614, Maharashtra, India.

  • +91 22 49731411/+91 2249731419

  • compliance@asstonpharmaceuticals.com

OUR LOCATION

Copyright 2022 | ASSTON PHARMACEUTICALS LTD. | All Rights Reserved | Website Developed by Blue Diamond Infotech

Go to Top